4.6 Review

The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance

期刊

ANNALS OF MEDICINE
卷 53, 期 1, 页码 611-625

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/07853890.2021.1890330

关键词

Parkinson’ s; α -synuclein; gut-brain axis; microbiome

资金

  1. MRC (UK)
  2. Parkinson UK
  3. Cure Parkinson Trust

向作者/读者索取更多资源

Gastrointestinal disorders are a significant issue for patients with Parkinson's disease, potentially caused by intestinal inflammation and changes in gut microbiota, but the mechanisms remain unclear. PD patients often experience a variety of gastrointestinal symptoms, impacting their quality of life. Despite research attention, understanding and management of gastrointestinal disorders in PD patients continue to be inadequate.
Gastrointestinal disorders are one of the most significant non-motor problems affecting people with Parkinson disease (PD). Pathogenetically, the gastrointestinal tract has been proposed to be the initial site of pathological changes in PD. Intestinal inflammation and alterations in the gut microbiota may contribute to initiation and progression of pathology in PD. However, the mechanisms underlying this gut-brain axis in PD remain unclear. PD patients can display a large variety of gastrointestinal symptoms, leading to reduced quality of life and psychological distress. Gastrointestinal disorders can also limit patients' response to medications, and consequently negatively impact on neurological outcomes. Despite an increasing research focus, gastrointestinal disorders in PD remain poorly understood and their clinical management often suboptimal. This review summarises our understanding of the relevance of the gut-brain axis to the pathogenesis of PD, discusses the impact of gastrointestinal disorders in patients with PD, and provides clinicians with practical guidance to their management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据